Page last updated: 2024-09-02

6-chloro-2-(1-piperazinyl)pyrazine and lithium chloride

6-chloro-2-(1-piperazinyl)pyrazine has been researched along with lithium chloride in 1 studies

Compound Research Comparison

Studies
(6-chloro-2-(1-piperazinyl)pyrazine)
Trials
(6-chloro-2-(1-piperazinyl)pyrazine)
Recent Studies (post-2010)
(6-chloro-2-(1-piperazinyl)pyrazine)
Studies
(lithium chloride)
Trials
(lithium chloride)
Recent Studies (post-2010) (lithium chloride)
1578243,883451,152

Protein Interaction Comparison

ProteinTaxonomy6-chloro-2-(1-piperazinyl)pyrazine (IC50)lithium chloride (IC50)
Glycogen synthase kinase-3 betaHomo sapiens (human)6.53

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, EK; Hass, RW; Kohut, SJ; Lefever, T; Prabandham, A; Walker, EA1

Other Studies

1 other study(ies) available for 6-chloro-2-(1-piperazinyl)pyrazine and lithium chloride

ArticleYear
Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice.
    Neuropharmacology, 2005, Volume: 49, Issue:8

    Topics: Animals; Avoidance Learning; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Lithium Chloride; Lysergic Acid Diethylamide; Male; Mianserin; Mice; Piperazines; Pyrazines; Receptor, Serotonin, 5-HT2C; Reinforcement, Psychology; Serotonin Antagonists; Taste

2005